To further evaluate the prognostic value of K-ras mutations in pancreatic cancer, we listed characteristics from the four studies that focused on the relationship between plasma K-ras mutations and pancreatic cancer prognosis [12, 28, 30, 31]. This evidence concerns the gene KRAS and pancreatic neoplasm.